Atropine — pharmacology, history, uses, and safety

Chemical characteristics and mechanism

Atropine is a racemic mixture of two enantiomers; one biologically active component is hyoscyamine. By binding to muscarinic receptors (M1–M5) without activating them, atropine inhibits parasympathetic nervous system effects. This antagonism produces predictable physiological changes such as increased heart rate, reduced secretions (saliva, bronchial, gastric), and relaxation of smooth muscle in the airways and gastrointestinal tract. In the eye, atropine causes long-lasting pupil dilation (mydriasis) and paralysis of the accommodation reflex (cycloplegia).

History and cultural notes

Historically, extracts of belladonna and related plants were used for diverse purposes including traditional medicine, cosmetics, and ritual. The name "atropine" derives from Atropos, one of the Fates in Greek myth, reflecting the compound's potency. The species name belladonna means "beautiful woman" in Italian; cosmetic use of eye-dilating extracts to enlarge pupils was fashionable in parts of Europe during the Renaissance. These cultural practices underline how botanical poisons were sometimes repurposed for perceived aesthetic or therapeutic benefit.

Medical uses and examples

Atropine remains on essential medicines lists because of several well-established medical indications. Common uses include:

• Ophthalmology: inducing mydriasis and cycloplegia for diagnostic procedures.
• Resuscitation and cardiology: treatment of symptomatic bradycardia and as an adjunct in some cardiac arrest algorithms to counter excessive vagal tone (resuscitate, cardiac arrest).
• Antidote therapy: as an antidote for organophosphate or certain nerve agent poisoning by blocking overstimulation of muscarinic receptors (antidote for poison gases and agricultural insecticides).
• Perioperative medicine: reducing secretions during anesthesia and counteracting vagal reflexes.

Toxicity, safety and dosing

Therapeutic and toxic doses of atropine are relatively close; mild anticholinergic effects include dry mouth, blurred vision, flushed skin, and tachycardia. Higher exposures produce confusion, hallucinations, severe hyperthermia, urinary retention, and potentially fatal outcomes if not treated. Clinical management of poisoning focuses on supportive care and, when appropriate, administration of specific antidotes and symptomatic therapies. Because of its potential to cause harm, atropine use requires careful dosing and monitoring.

Distinctions and notable facts

Atropine should be distinguished from related antimuscarinic agents (for example, ipratropium or scopolamine) by differences in receptor selectivity, duration of action, and clinical indications. It is included on the World Health Organization's essential medicines list as a core medication for basic healthcare systems (WHO essential list). For historical plant sources and alkaloid chemistry see specialized botanical and pharmacological references; for clinical protocols consult relevant medical guidelines. Additional background information is available through pharmacology texts and trusted medical resources (Renaissance cosmetic history, alkaloid class, therapeutic use).

For further reading and practical guidance, consult authoritative clinical guidelines and toxicology resources: alkaloid overview, belladonna, mandrake, drug monographs, WHO list, historical context, resuscitation use, cardiac guidance, antidote role, nerve agents, organophosphate pesticides.